---
category: listing
circular_id: 8233543d0bb65273
date: '2025-09-04'
description: NSE announces listing of Snehaa Organics Limited equity shares on EMERGE
  SME Platform effective September 05, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70023.zip
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: New SME listing with specific trading arrangements and lock-in provisions
  affecting market participants
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70023.zip
processing:
  attempts: 1
  content_hash: 587806c7b217f45c
  processed_at: '2025-09-04T15:28:43.717337'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-09-04T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70023.zip
severity: medium
source: nse
stocks:
- SNEHAA
tags:
- continuous-market
- emerge-platform
- listing
- sme
- snehaa-organics
- trade-for-trade
title: Listing of Equity Shares of Snehaa Organics Limited (SME IPO)
---

## Summary

NSE announces the listing of Snehaa Organics Limited equity shares on the EMERGE SME Platform effective September 05, 2025. The company will trade under symbol SNEHAA with ISIN INE1OIC01018, initially in Trade for Trade Surveillance Segment (TFTS) before transitioning to normal rolling segment.

## Key Points

- Company Symbol: SNEHAA
- ISIN: INE1OIC01018
- Face Value: Rs. 10/- per share
- IPO Issue Price: Rs. 122/- per share
- Total Securities: 10,179,000 equity shares
- Market Lot: 1,000 equity shares
- Trading Series: ST (Trade for Trade Surveillance Segment)
- Market Maker: Nirman Share Brokers Private Limited
- Registrar: Skyline Financial Services Private Limited

## Regulatory Changes

- Initial trading in Series 'ST' (TFTS - Settlement Type 'W')
- Subsequent shift to Series 'SM' (Normal Rolling Segment - Settlement Type 'N')
- Part of pre-open session for IPO and Other category scrips
- Available for continuous market trading
- Market maker maximum permissible spread within 10%

## Compliance Requirements

- Members must use designated security codes for trading
- Trading must be in specified lot sizes of 1,000 shares
- Securities will be identified only by designated codes
- Compliance with SEBI circulars CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012

## Important Dates

- **Effective Date**: September 05, 2025
- **Lock-in Period**: Until September 29, 2026 (for certain shareholdings)
- **Financial Year**: April 2025 - March 2026

## Impact Assessment

Medium impact on SME segment participants. New listing provides additional trading opportunities in pharmaceutical sector. Trade-for-trade surveillance indicates heightened monitoring. Lock-in provisions affect liquidity for significant portion of shares. Market makers ensure liquidity support during initial trading period.